SWI/SNF-deficient tumors of the central nervous system: An update

Martin Hasselblatt*, Marcel Kool, Michael C. Frühwald

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant tumor of the central nervous system characterized by biallelic inactivation of SWI/SNF chromatin remodeling complex members SMARCB1/ INI1 or (rarely) SMARCA4/BRG1. Most high-grade central nervous system lesions showing loss of nuclear SMARCB1 or SMARCA4 protein expression can indeed be categorized as AT/RT. However, some high-grade lesions have been identified, whose clinical and/or molecular features justify separation from AT/RT. Furthermore, other recently described tumor types such as desmoplastic myxoid tumor, SMARCB1-mutant, and low-grade diffusely infiltrative tumor, SMARCB1-mutant, may even manifest as low-grade lesions. Here, we review recent developments in the definition of the molecular landscape of AT/RT and give an update on other rare high- and low-grade SWI/SNF-deficient central nervous system tumors.

Original languageEnglish
Pages (from-to)2-9
Number of pages8
JournalClinical Neuropathology
Volume43
Issue number1
DOIs
Publication statusPublished - Jan 2024

Keywords

  • DNA methylation profiling
  • malignant rhabdoid tumor
  • neuropathology
  • SMARCA4
  • SMARCB1

Fingerprint

Dive into the research topics of 'SWI/SNF-deficient tumors of the central nervous system: An update'. Together they form a unique fingerprint.

Cite this